Nomura Asset Management Co. Ltd. Decreases Stake in Revvity Inc. $RVTY

Nomura Asset Management Co. Ltd. lowered its position in shares of Revvity Inc. (NYSE:RVTY) by 91.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,544 shares of the company’s stock after selling 36,425 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Revvity were worth $343,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the company. MUFG Securities EMEA plc grew its holdings in shares of Revvity by 109.2% during the 4th quarter. MUFG Securities EMEA plc now owns 4,648 shares of the company’s stock worth $450,000 after purchasing an additional 2,426 shares during the period. Norges Bank acquired a new position in Revvity during the 4th quarter worth approximately $80,382,000. Eurizon Capital SGR S.p.A. acquired a new position in Revvity during the 4th quarter worth approximately $7,691,000. Northwestern Mutual Wealth Management Co. lifted its position in Revvity by 7.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 4,682 shares of the company’s stock worth $453,000 after acquiring an additional 336 shares in the last quarter. Finally, Cary Street Partners Financial LLC lifted its position in Revvity by 1.6% during the 4th quarter. Cary Street Partners Financial LLC now owns 8,941 shares of the company’s stock worth $865,000 after acquiring an additional 141 shares in the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Price Performance

RVTY stock opened at $98.46 on Friday. The company has a quick ratio of 1.41, a current ratio of 1.72 and a debt-to-equity ratio of 0.37. Revvity Inc. has a 52-week low of $81.22 and a 52-week high of $118.30. The stock’s 50 day moving average is $93.40 and its two-hundred day moving average is $97.49. The company has a market capitalization of $10.98 billion, a PE ratio of 47.11, a P/E/G ratio of 2.24 and a beta of 1.11.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The business had revenue of $711.12 million during the quarter, compared to the consensus estimate of $704.07 million. During the same period in the previous year, the business earned $1.01 EPS. The business’s quarterly revenue was up 7.0% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Analysts predict that Revvity Inc. will post 5.25 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Friday, July 17th. Revvity’s payout ratio is 13.40%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on RVTY. Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Wolfe Research started coverage on shares of Revvity in a research report on Tuesday. They set a “peer perform” rating on the stock. Weiss Ratings cut shares of Revvity from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, May 13th. JPMorgan Chase & Co. reduced their target price on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 6th. Finally, The Goldman Sachs Group reduced their target price on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 14th. Four equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Revvity presently has an average rating of “Hold” and a consensus target price of $107.73.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.